GNCA
Genocea Biosciences, Inc.
GNCA
GNCA
Delisted
GNCA was delisted on the 2nd of June, 2022.
39 hedge funds and large institutions have $63.4M invested in Genocea Biosciences, Inc. in 2020 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 11 increasing their positions, 11 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 11
Holders
39
Holding in Top 10
1
Calls
$992K
Puts
$269K
Top Buyers
| 1 | +$11.6M | |
| 2 | +$7.22M | |
| 3 | +$4.57M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$4.03M |
| 5 |
BC
Boxer Capital
San Diego,
California
|
+$2.6M |
Top Sellers
| 1 | -$1.21M | |
| 2 | -$276K | |
| 3 | -$242K | |
| 4 |
JJIJ
Johnson & Johnson Innovation - JJDC
New Brunswick,
New Jersey
|
-$231K |
| 5 |
FIA
FNY Investment Advisers
New York
|
-$229K |